Exploring patient participation in reducing health-care-related safety risks
Exploring patient participation in reducing health-care-related safety risks
Exploring patient participation in reducing health-care-related safety risks
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
» engag<strong>in</strong>g with <strong>patient</strong> representatives <strong>in</strong> cases where <strong>patient</strong>s are not (fully) capable<br />
of voic<strong>in</strong>g their wishes or exercis<strong>in</strong>g their rights because of (partial) <strong>in</strong>competency<br />
or other reasons; and<br />
» appo<strong>in</strong>t<strong>in</strong>g a <strong>patient</strong> advocate as part of a comprehensive compla<strong>in</strong>t system.<br />
The right to privacy<br />
In an era <strong>in</strong> which <strong>in</strong>formation technology is rapidly expand<strong>in</strong>g <strong>in</strong> <strong>health</strong> as well as <strong>in</strong><br />
other parts of society, it is crucial to protect <strong>patient</strong>s’ privacy rights. Privacy <strong>in</strong> <strong>health</strong><br />
<strong>care</strong> is traditionally realized through the legal and professional norms of medical<br />
confidentiality. As a general rule, <strong>health</strong> <strong>care</strong> professionals are supposed not to disclose<br />
<strong>patient</strong> <strong>in</strong>formation to other <strong>in</strong>dividuals or parties except when legitimized by <strong>patient</strong><br />
consent, legal obligations or emergency circumstances.<br />
Rules on medical confidentiality may create problems <strong>in</strong> the context of quality<br />
improvement when, for <strong>in</strong>stance, quality improvement schemes require coded or<br />
identifiable <strong>patient</strong> <strong>in</strong>formation and medical confidentiality and/or privacy regulations<br />
prohibit this. The same problem may rise <strong>in</strong> national or <strong>in</strong>ternational medical research<br />
<strong>in</strong>to <strong>patient</strong> <strong>safety</strong> and quality of <strong>care</strong>. It is obvious that privacy protection is an<br />
important part of <strong>in</strong>dividual <strong>patient</strong>s’ legal position, but they (and <strong>patient</strong>s of the<br />
future) may benefit from the outcomes of quality assurance schemes and <strong>patient</strong> <strong>safety</strong><br />
medical research. It is important to balance the privacy <strong>in</strong>terests of <strong>in</strong>dividual <strong>patient</strong>s<br />
with societal <strong>in</strong>terest <strong>in</strong> improv<strong>in</strong>g the <strong>safety</strong> and quality of <strong>health</strong> <strong>care</strong>, if necessary by<br />
allow<strong>in</strong>g exceptions to the general rules on privacy and medical confidentiality. Adverse<br />
event report<strong>in</strong>g procedures, for <strong>in</strong>stance, may underperform if approaches such as us<strong>in</strong>g<br />
identifiable <strong>patient</strong> data to check whether the reported <strong>in</strong>formation is complete or<br />
ask<strong>in</strong>g for more <strong>in</strong>formation from the <strong>health</strong> professional who reported the event are<br />
forbidden, at least <strong>in</strong> the first phase of the report<strong>in</strong>g process.<br />
It can be assumed that, <strong>in</strong> general, <strong>patient</strong>s do not object to their identifiable data<br />
be<strong>in</strong>g used for quality and <strong>safety</strong>-improvement purposes. Important preconditions are<br />
that <strong>patient</strong>s receive general <strong>in</strong>formation about the possibility that their data may be<br />
used and are given the opportunity to object, identifiable data are only used when less<br />
<strong>in</strong>trusive options are not possible and adequate safeguards are put <strong>in</strong> place. 2<br />
Additional aspects<br />
Legal rights described <strong>in</strong> the previous section cannot be isolated from the context and<br />
circumstances <strong>in</strong> which they are to be exercised and implemented. It will be difficult<br />
to bridge the gap between legal provisions and the daily practice of <strong>health</strong> <strong>care</strong> if this<br />
connection is ignored. A number of additional aspects should be taken <strong>in</strong>to account<br />
when work<strong>in</strong>g to empower <strong>patient</strong>s through legal means.<br />
2 This will usually require legislation. See, for <strong>in</strong>stance, Article 60 of the Health and Social Care Act 2001 from United<br />
K<strong>in</strong>gdom (England) (33) which, under certa<strong>in</strong> conditions, allows the use of confidential <strong>patient</strong> <strong>in</strong>formation for quality<br />
protection purposes. A similar approach can be found <strong>in</strong> the United States’ Patient Safety and Quality Improvement Act<br />
of 2005 (18). The Government of the Netherlands <strong>in</strong>troduced a bill <strong>in</strong> Parliament with a similar provision <strong>in</strong> 2010. More<br />
extensive analysis of this legislation is provided by De Roode & Legemaate (34).<br />
Patients’ rights and <strong>patient</strong> <strong>safety</strong><br />
21